Forward Management LLC boosted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.5% during the second quarter, Holdings Channel reports. The firm owned 1,197,725 shares of the real estate investment trust’s stock after buying an additional 40,900 shares during the period. Sabra Healthcare REIT comprises 2.5% of Forward Management LLC’s investment portfolio, making the stock its 10th largest position. Forward Management LLC’s holdings in Sabra Healthcare REIT were worth $28,864,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in SBRA. Global X Management Co. LLC boosted its stake in Sabra Healthcare REIT by 4.8% in the second quarter. Global X Management Co. LLC now owns 351,888 shares of the real estate investment trust’s stock valued at $8,481,000 after buying an additional 16,129 shares during the period. Sei Investments Co. boosted its stake in Sabra Healthcare REIT by 7.7% in the second quarter. Sei Investments Co. now owns 25,849 shares of the real estate investment trust’s stock valued at $623,000 after buying an additional 1,841 shares during the period. Texas Permanent School Fund boosted its stake in Sabra Healthcare REIT by 0.8% in the second quarter. Texas Permanent School Fund now owns 47,667 shares of the real estate investment trust’s stock valued at $1,149,000 after buying an additional 400 shares during the period. Daiwa Securities Group Inc. boosted its stake in Sabra Healthcare REIT by 15.7% in the second quarter. Daiwa Securities Group Inc. now owns 5,900 shares of the real estate investment trust’s stock valued at $142,000 after buying an additional 800 shares during the period. Finally, Great West Life Assurance Co. Can boosted its stake in Sabra Healthcare REIT by 17.9% in the second quarter. Great West Life Assurance Co. Can now owns 110,774 shares of the real estate investment trust’s stock valued at $2,667,000 after buying an additional 16,820 shares during the period. 99.26% of the stock is owned by institutional investors.

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) opened at 22.19 on Thursday. The firm has a market capitalization of $1.45 billion, a PE ratio of 18.68 and a beta of 0.89. The company’s 50 day moving average price is $23.53 and its 200-day moving average price is $25.35. Sabra Healthcare REIT, Inc. has a 52 week low of $19.30 and a 52 week high of $29.10.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a net margin of 34.99% and a return on equity of 8.72%. The firm had revenue of $62.65 million during the quarter, compared to the consensus estimate of $63.47 million. During the same quarter in the previous year, the company posted $0.54 earnings per share. The firm’s revenue was up .1% on a year-over-year basis. On average, equities research analysts expect that Sabra Healthcare REIT, Inc. will post $1.21 EPS for the current fiscal year.

The company also recently declared a dividend, which will be paid on Friday, August 18th. Stockholders of record on Wednesday, August 16th will be paid a $0.3599 dividend. The ex-dividend date of this dividend is Monday, August 14th. Sabra Healthcare REIT’s payout ratio is 145.76%.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.watchlistnews.com/forward-management-llc-has-28-86-million-position-in-sabra-healthcare-reit-inc-nasdaqsbra/1470167.html.

Several research firms have recently commented on SBRA. Zacks Investment Research raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday. Stifel Nicolaus reissued a “hold” rating and issued a $26.00 target price on shares of Sabra Healthcare REIT in a research note on Friday, July 28th. BidaskClub raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. Mizuho cut Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $25.00 to $23.00 in a research note on Monday, July 10th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $25.00 target price (down from $28.00) on shares of Sabra Healthcare REIT in a research note on Sunday, July 9th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. Sabra Healthcare REIT presently has an average rating of “Hold” and a consensus price target of $26.57.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.